Unknown

Dataset Information

0

Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates.


ABSTRACT: Approaches toward new therapeutics using disease genomics, such as genome-wide association study (GWAS), are anticipated. Here, we developed Trans-Phar [integration of transcriptome-wide association study (TWAS) and pharmacological database], achieving in silico screening of compounds from a large-scale pharmacological database (L1000 Connectivity Map), which have inverse expression profiles compared with tissue-specific genetically regulated gene expression. Firstly we confirmed the statistical robustness by the application of the null GWAS data and enrichment in the true-positive drug-disease relationships by the application of UK-Biobank GWAS summary statistics in broad disease categories, then we applied the GWAS summary statistics of large-scale European meta-analysis (17 traits; naverage = 201 849) and the hospitalized COVID-19 (n = 900 687), which has urgent need for drug development. We detected potential therapeutic compounds as well as anisomycin in schizophrenia (false discovery rate (FDR)-q = 0.056) and verapamil in hospitalized COVID-19 (FDR-q = 0.068) as top-associated compounds. This approach could be effective in disease genomics-driven drug development.

SUBMITTER: Konuma T 

PROVIDER: S-EPMC7928862 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4544055 | biostudies-literature
| S-EPMC7164172 | biostudies-literature
| S-EPMC5457674 | biostudies-literature
| S-EPMC1475624 | biostudies-literature
| S-EPMC3779154 | biostudies-literature
| S-EPMC5358695 | biostudies-literature
| S-EPMC8020993 | biostudies-literature
| S-EPMC8192542 | biostudies-literature
| S-EPMC7991048 | biostudies-literature
| S-EPMC10952035 | biostudies-literature